The Discounted Cash Flow (DCF) valuation of Nurix Therapeutics Inc (NRIX) is (120.89) USD. With the latest stock price at 11.21 USD, the upside of Nurix Therapeutics Inc based on DCF is -1178.4%.
Based on the latest price of 11.21 USD and our DCF valuation, Nurix Therapeutics Inc (NRIX) is a sell. selling NRIX stocks now will result in a potential gain of 1178.4%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 9.8% | 7.9% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (430.34) - (71.68) | (120.89) |
| Upside | -3938.9% - -739.4% | -1178.4% |